Prelude Therapeutics (PRLD) Prepaid Assets (2019 - 2026)

Prelude Therapeutics has disclosed Prepaid Assets across 8 years of filings, most recently posting $3.0 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $3.0 million, down 8.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 8.71% YoY), and the FY2025 annual result was $2.5 million, up 8.64% from the prior year.
• Prepaid Assets came in at $3.0 million for Q1 2026 at Prelude Therapeutics, up from $2.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $5.2 million in Q2 2023 to a low of $2.3 million in Q4 2024.
• The 5-year median for Prepaid Assets is $3.0 million (2023), against an average of $3.2 million.
• Across the five-year window, Prepaid Assets jumped 125.14% in 2023 and tumbled 45.03% in 2024, its largest moves.
• Prelude Therapeutics' Prepaid Assets stood at $2.7 million in 2022, then gained by 0.08% to $2.7 million in 2023, then dropped by 14.05% to $2.3 million in 2024, then grew by 8.64% to $2.5 million in 2025, then rose by 22.64% to $3.0 million in 2026.
• The last three Prepaid Assets figures came in at $3.0 million (Q1 2026), $2.5 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.